Senior Scientist
Memorial Sloan Kettering Cancer Center, United States
I am a multidisciplinary scientist, devoted to life sciences since my undergraduate studies in Chemical Engineering. During my Ph.D. in ETH Zurich, Switzerland, I discovered a relationship between cell cycle and cancer migration, using nano/micro-fabrication tools to create artificial environments mimicking human tissue. After my Ph.D., I worked as an R&D Manager for two years in a blood diagnostics startup company in Switzerland, where I set up from scratch two complete research labs and monitored the activities of a team of 10 scientists and engineers, focusing on the product’s preclinical development.
In the Cancer Nanomedicine Lab, I am in charge of the design and preclinical testing of lipid or polymeric nanoparticle drug delivery systems, for the targeted treatment of cancer or acute kidney injury. I have developed a new class of versatile lipid nanoparticles that have shown high therapeutic efficacy in mouse models of Graft-vs-Host-Disease and pancreatic ductal adenocarcinoma. Apart from nanoparticles for drug delivery, I am also developing hydrogels with shape memory for tissue regeneration after cancer therapy.
Disclosure information not submitted.
Artificial Intelligence and Predictive Models in Pharmaceutical Technologies
Thursday, July 11, 2024
9:00 AM – 11:00 AM CET
